drugset / Trial / NCT02618629
Mass Balance and Metabolism Study of 14C-Z-215
NaSingle-groupOpen-labelBasic science
Summary
The aim of this Phase I study is to determine the absorption, metabolism, and excretion of 14C-Z-215 in healthy male subjects following a single oral administration at a therapeutically relevant dose level (20 mg).
Timeline
- Start
- 2016-01
- Primary completion
- 2016-06
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZELOPRAZOLE | Small molecule | 20 mg | Oral |
Indications
No indication recorded.